Identifying target ion channel-related genes to construct a diagnosis model for insulinoma

Shuangyang Mo1,2, Yingwei Wang1, Wenhong Wu1

  • 1Gastroenterology Department, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, China.

Frontiers in Genetics
|September 29, 2023
PubMed

Insights

Researchers identified three key ion channel-related genes and developed a diagnostic model for insulinoma, offering a new approach for early detection and understanding of this common pancreatic neuroendocrine tumor.

Area of Science:

  • Biomedical research
  • Genomics
  • Oncology

Background:

  • Insulinoma, the most frequent functional pancreatic neuroendocrine tumor (PNET), is characterized by abnormal insulin hypersecretion.
  • The precise causes of insulinoma remain unclear, necessitating novel diagnostic strategies.
  • This study investigates ion channel-related genes to elucidate molecular mechanisms and establish a genetic diagnosis model for insulinoma.

Purpose of the Study:

  • To identify key ion channel-related genes implicated in insulinoma pathogenesis.
  • To develop and validate a predictive diagnostic model for insulinoma using machine learning.
  • To explore the molecular pathways and immune microenvironment associated with identified genes.

Main Methods:

  • Analysis of mRNA expression profiles from insulinoma, nonfunctional PNET, and normal islet samples.
  • Identification of differentially expressed ion channel-related genes (DEICRGs) using bioinformatics and machine learning (LASSO, SVM-RFE).
  • Construction and validation of a nomogram diagnostic model using receiver operating characteristic (ROC) curves, alongside immune infiltration and gene set enrichment analyses (GSEA, GSVA).

Main Results:

  • Twenty-nine DEICRGs were identified, enriched in pathways related to ion transport, homeostasis, pancreatic secretion, and lysosomes.
  • Three target genes (MCOLN1, ATP6V0E1, ATP4A) were pinpointed via protein-protein interaction (PPI) and machine learning.
  • A diagnostic model based on these genes demonstrated high predictive accuracy (AUC = 0.801), correlating positively with insulin secretion and lysosome function, and negatively with TGF-beta signaling.

Conclusions:

  • Three specific ion channel-related genes have been identified as potential biomarkers for insulinoma.
  • A novel, efficient diagnostic model utilizing these genes offers a promising tool for insulinoma diagnosis.
  • Further research into these genes and pathways could reveal new therapeutic targets for insulinoma.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K